QA – Page 50 – Pharma.Tips

Cleaning Deviation Due to Operator Error: Why Retraining Alone Is Not Enough

Addressing Cleaning Deviations Linked to Operator Error: Beyond Simple Retraining Cleaning deviations in pharmaceutical manufacturing remain a prevalent issue, often stemming from operator errors. Such lapses can lead to contamination,…

Campaign Manufacturing and Dedicated Equipment Decision Criteria

Decision-Making Framework for Campaign Manufacturing and Dedicated Equipment Risks In the pharmaceutical manufacturing landscape, campaign manufacturing presents specific challenges, notably the increased risk of cross-contamination and the need for meticulous…

How to Investigate Visual Residue After Approved Cleaning Cycle

How to Effectively Investigate Visual Residue After Cleaning Cycles In pharmaceutical manufacturing, ensuring equipment cleanliness is paramount to maintaining product quality and regulatory compliance. Visual residue post-cleaning can indicate potential…

Role of HBEL and PDE in Campaign Manufacturing Risk Control

Understanding the Role of HBEL and PDE in Mitigating Campaign Manufacturing Risks In pharmaceutical manufacturing, especially during campaign-based production, the risk of contamination and cross-contamination rises significantly. The complexity of…

Cleaning Deviation Closure Criteria: What QA Should Verify Before Approval

Effective Strategies for Addressing Cleaning Deviation Approval Criteria in QA In pharmaceutical manufacturing, deviations in cleaning processes can have significant implications for product quality, compliance, and overall operational efficiency. Cleaning…

Campaign Manufacturing CAPA Examples for Cross-Contamination Events

Managing CAPA for Cross-Contamination in Campaign Manufacturing Cross-contamination remains a significant risk in campaign manufacturing, particularly in facilities that produce multiple products in succession. The challenge escalates as companies strive…

Cleaning CAPA Documentation Checklist for FDA and EU GMP Inspections

Effective Implementation of CAPA for Cleaning Deviations in Pharma Cleaning deviations can disrupt the pharmaceutical manufacturing process and pose risks to product quality and patient safety. When such deviations occur,…

How to Handle Partial Cleaning Between Campaign Lots

Effective Strategies for Managing Partial Cleaning During Campaign Production Partial cleaning between campaign lots poses significant risks in pharmaceutical manufacturing, leading to potential cross-contamination, compliance failures, and compromised product integrity.…

How to Perform Batch Impact Assessment After Cleaning Failure

Conducting a Comprehensive Batch Impact Assessment Following a Cleaning Failure In the pharmaceutical manufacturing environment, ensuring effective cleaning processes is critical to maintaining product integrity and regulatory compliance. Cleaning deviations…

Campaign Manufacturing Risks in Sterile and Non-Sterile Areas

Addressing Campaign Manufacturing Risks in Sterile and Non-Sterile Areas In pharmaceutical manufacturing, the complexities associated with campaign production can lead to significant risks, particularly concerning cross-contamination and compliance with Good…

Cleaning Deviation Response Plan for Sterile Manufacturing Areas

Effective Response Plans for Cleaning Deviations in Sterile Manufacturing Environments Cleaning deviations in sterile manufacturing areas can lead to serious implications for product quality and regulatory compliance. Professionals in the…

Campaign Manufacturing Risk Controls for OSD Facilities

Addressing Campaign Manufacturing Risks in OSD Facilities Campaign manufacturing in Oral Solid Dosage (OSD) facilities brings unique challenges, particularly around the risks of contamination and cross-contamination. High variability in product…